Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis

Nat Med. 2016 Feb;22(2):154-62. doi: 10.1038/nm.4035. Epub 2016 Jan 18.

Abstract

Although the lung can undergo self-repair after injury, fibrosis in chronically injured or diseased lungs can occur at the expense of regeneration. Here we study how a hematopoietic-vascular niche regulates alveolar repair and lung fibrosis. Using intratracheal injection of bleomycin or hydrochloric acid in mice, we show that repetitive lung injury activates pulmonary capillary endothelial cells (PCECs) and perivascular macrophages, impeding alveolar repair and promoting fibrosis. Whereas the chemokine receptor CXCR7, expressed on PCECs, acts to prevent epithelial damage and ameliorate fibrosis after a single round of treatment with bleomycin or hydrochloric acid, repeated injury leads to suppression of CXCR7 expression and recruitment of vascular endothelial growth factor receptor 1 (VEGFR1)-expressing perivascular macrophages. This recruitment stimulates Wnt/β-catenin-dependent persistent upregulation of the Notch ligand Jagged1 (encoded by Jag1) in PCECs, which in turn stimulates exuberant Notch signaling in perivascular fibroblasts and enhances fibrosis. Administration of a CXCR7 agonist or PCEC-targeted Jag1 shRNA after lung injury promotes alveolar repair and reduces fibrosis. Thus, targeting of a maladapted hematopoietic-vascular niche, in which macrophages, PCECs and perivascular fibroblasts interact, may help to develop therapy to spur lung regeneration and alleviate fibrosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / toxicity
  • Bleomycin / toxicity
  • Calcium-Binding Proteins / antagonists & inhibitors
  • Calcium-Binding Proteins / metabolism*
  • Capillaries / drug effects
  • Capillaries / metabolism*
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelial Cells / physiology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fibrosis
  • Fluorescent Antibody Technique
  • Humans
  • Hydrochloric Acid / toxicity
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Jagged-1 Protein
  • Lung / drug effects
  • Lung / metabolism*
  • Lung / pathology
  • Lung / physiology
  • Lung Injury / metabolism*
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / metabolism*
  • Mice
  • Oligopeptides / pharmacology
  • Pulmonary Artery / drug effects
  • Pulmonary Artery / metabolism
  • Pulmonary Circulation / drug effects
  • Pulmonary Circulation / physiology
  • Pulmonary Fibrosis / metabolism*
  • RNA, Small Interfering / pharmacology
  • Receptors, CXCR / agonists
  • Receptors, CXCR / metabolism*
  • Receptors, Notch / metabolism
  • Regeneration / drug effects
  • Regeneration / physiology*
  • Serrate-Jagged Proteins
  • Smad3 Protein / drug effects
  • Smad3 Protein / metabolism
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism
  • Wnt Signaling Pathway

Substances

  • Antibiotics, Antineoplastic
  • Calcium-Binding Proteins
  • Cmkor1 protein, mouse
  • Intercellular Signaling Peptides and Proteins
  • JAG1 protein, human
  • Jag1 protein, mouse
  • Jagged-1 Protein
  • Membrane Proteins
  • Oligopeptides
  • RNA, Small Interfering
  • Receptors, CXCR
  • Receptors, Notch
  • Serrate-Jagged Proteins
  • Smad3 Protein
  • Smad3 protein, mouse
  • TC14012
  • Bleomycin
  • Vascular Endothelial Growth Factor Receptor-1
  • Hydrochloric Acid